DK0670837T3 - - Google Patents

Info

Publication number
DK0670837T3
DK0670837T3 DK94900718.1T DK94900718T DK0670837T3 DK 0670837 T3 DK0670837 T3 DK 0670837T3 DK 94900718 T DK94900718 T DK 94900718T DK 0670837 T3 DK0670837 T3 DK 0670837T3
Authority
DK
Denmark
Prior art keywords
pct
date jun
carbolines
beta
sec
Prior art date
Application number
DK94900718.1T
Other languages
Danish (da)
English (en)
Inventor
Gregor Haffer
Klaus Nickisch
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0670837T3 publication Critical patent/DK0670837T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK94900718.1T 1992-11-24 1993-11-22 DK0670837T3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4240672A DE4240672A1 (de) 1992-11-24 1992-11-24 Neues Verfahren zur Herstellung von beta-Carbolinen

Publications (1)

Publication Number Publication Date
DK0670837T3 true DK0670837T3 (fr) 1997-03-10

Family

ID=6474299

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94900718.1T DK0670837T3 (fr) 1992-11-24 1993-11-22

Country Status (10)

Country Link
US (1) US5569661A (fr)
EP (1) EP0670837B1 (fr)
JP (1) JPH08503224A (fr)
AT (1) ATE144259T1 (fr)
CA (1) CA2149303A1 (fr)
DE (2) DE4240672A1 (fr)
DK (1) DK0670837T3 (fr)
ES (1) ES2095148T3 (fr)
GR (1) GR3021686T3 (fr)
WO (1) WO1994012498A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688807A (en) * 1994-03-11 1997-11-18 Eli Lilly And Company Method for treating 5HT2B receptor related conditions
JP5501251B2 (ja) 2008-01-11 2014-05-21 アルバニー モレキュラー リサーチ， インコーポレイテッド Ｍｃｈ拮抗薬としての（１−アジノン）置換ピリドインドール類
US9073925B2 (en) * 2009-07-01 2015-07-07 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2011003007A1 (fr) * 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Antagonistes de mch-1 d’azabicycloalcane-indole et d’azabicycloalcane-pyrrolo-pyridine, procédés de préparation, et utilisation de ceux-ci
WO2011003012A1 (fr) * 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Antagonistes de mch-1 azapolycycles substitués par azinone, leurs procédés de fabrication et leur utilisation
EP2448585B1 (fr) * 2009-07-01 2014-01-01 Albany Molecular Research, Inc. Antagonistes de mch-1 d azépino[b]indole et pyrido-pyrrolo-azépine azinone-substitué, procédés de préparation, et utilisation de ceux-ci
US8697700B2 (en) 2010-12-21 2014-04-15 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
US8993765B2 (en) 2010-12-21 2015-03-31 Albany Molecular Research, Inc. Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
CN102558118B (zh) * 2011-12-28 2014-06-25 北京颖泰嘉和生物科技有限公司 一种制备4-甲基邻苯二甲酸酐的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3504045A1 (de) * 1985-02-04 1986-08-07 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von ss-carbolinen durch dehydrierung
DE3540653A1 (de) * 1985-11-13 1987-05-14 Schering Ag Neue 3-oxadiazol- und 3-carbonsaeure-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
DE3608089A1 (de) * 1986-03-08 1987-09-10 Schering Ag Heteroaryl-oxy-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
DE4029389A1 (de) * 1990-09-13 1992-03-26 Schering Ag Verfahren zur herstellung von (beta)-carbolin-derivaten

Also Published As

Publication number Publication date
DE4240672A1 (de) 1994-05-26
CA2149303A1 (fr) 1994-06-09
JPH08503224A (ja) 1996-04-09
US5569661A (en) 1996-10-29
WO1994012498A1 (fr) 1994-06-09
EP0670837A1 (fr) 1995-09-13
ES2095148T3 (es) 1997-02-01
ATE144259T1 (de) 1996-11-15
EP0670837B1 (fr) 1996-10-16
GR3021686T3 (en) 1997-02-28
DE59304218D1 (de) 1996-11-21

Similar Documents

Publication Publication Date Title
ZA939621B (en) Protein named component B
ZA947969B (en) Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
AU6226494A (en) Spiroazacyclic derivatives as substance p antagonists
HUT62259A (en) Process for enantioselective production of phenylisoserine derivatives
DK0699207T3 (da) Mellemprodukt til azithromycin
PT687260E (pt) Processo para a preparacao de 9-desoxotaxanos
SE9502921D0 (sv) New compounds
DK0670837T3 (fr)
CA2267165A1 (fr) Utilisation de 1-hydroxy-2-pyridone pour le traitement de l'eczema seborrheique
FI950892A0 (fi) Entsymaattinen asymmetrinen pelkistysmenetelmä 4-H-tieno-(2,3-6) tiopyraanijohdannaisten tuottamiseksi
DK0931161T3 (da) Fremgangsmåde til biotransformation af colchicinoid-forbindelser til de tilsvarende 3-glycosylderivater
CA2047714A1 (fr) Procede d'obtention par fermentation d'acide 2-(4-hydroxyphenoxy)propionique
JPS56128776A (en) Alpha-methylene gamma-butyrolactone derivative
AU674909B2 (en) New triazoloquinazolines, their production and their use
HU9503666D0 (en) Process for producing prostanoide
GB9217823D0 (en) Chemical process
AU5269696A (en) Anellated beta-carbolines
MX9703846A (es) Nuevos derivados de 10, 11-dihidro-10-oxo-5h-dibenz/b, f/azepina-5-carboxamida.